FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4566311000001105: Lipobay 300microgram tablets (Bayer Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17918701000001112 Lipobay 300microgram tablets (Bayer Plc) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17918801000001115 Lipobay 300microgram tablets (Bayer Plc) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lipobay 300microgram tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lipobay 300microgram tablets (Bayer Plc) Is a Product containing precisely cerivastatin sodium 300 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lipobay 300microgram tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Lipobay 300microgram tablets (Bayer Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lipobay 300microgram tablets (Bayer Plc) Has active ingredient Cerivastatin sodium false Inferred relationship Existential restriction modifier
Lipobay 300microgram tablets (Bayer Plc) VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Lipobay 300microgram tablets (Bayer Plc) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Lipobay 300microgram tablets (Bayer Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Lipobay 300microgram tablets (Bayer Plc) Is a Lipobay true Inferred relationship Existential restriction modifier
Lipobay 300microgram tablets (Bayer Plc) Has specific active ingredient Cerivastatin sodium true Inferred relationship Existential restriction modifier
Lipobay 300microgram tablets (Bayer Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lipobay 300microgram tablets (Bayer Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lipobay 300microgram tablets (Bayer Plc) 28 tablet Is pack of False Lipobay 300microgram tablets (Bayer Plc) Inferred relationship Existential restriction modifier
Lipobay 300microgram tablets (Bayer Plc) 28 tablet Has AMP True Lipobay 300microgram tablets (Bayer Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start